https://doi.org/10.55788/a8c6eab8
“We are increasingly approaching the human body as a machine that is continuously monitored,” said Dr Zink. “Face masks that can measure breathing patterns, smart textiles that can measure skin temperature and metabolites, and smartwatches that can track activity, sleep, heart rate, and blood oxygen levels are just some of the devices that have been developed or are in the pipeline for monitoring the ‘human machine’ [2].” Integrated wearable microneedles to monitor biomarkers in the interstitial fluid, wireless patches to track C-reactive protein in sweat, and a wearable nano-biosensor to monitor female hormones are some other novel monitoring options. “But we don’t want one wearable for diabetes, and another for cardiovascular issues; ideally, we would have one solution for all of it,” according to Dr Zink. One innovation aiming to monitor many parameters simultaneously is the development of nucleic acid-based wearable and implantable electrochemical sensors. These could be adjusted to the individual’s needs, measuring biomarkers of interest to track certain health conditions [3].
Dr Zink argued that this monitoring will not stop at the body but will extend into an individual’s environment. “There are mattresses that can track nocturnal scratching in atopic dermatitis and refrigerators that can track dietary habits in patients with hidradenitis suppurativa [4],” he said. “Also, an innovative smart mirror can analyse the skin, providing personalised skin care recommendations.” In addition, this tool can non-invasively track blood sugar by observing the colour of a person’s lips [5]. Furthermore, smart toilets capable of analysing urine and stool, as well as conducting other measurements, are currently in development [6].
In dermatology, these monitoring tools and innovations are particularly helpful when used alongside a dermatologist's assessment. It has been demonstrated that the diagnostic performance of a dermatologist working in collaboration with a convolutional neural network is superior to the diagnostic performance of either one alone [7].
Other promising applications of AI in dermatology include communication tools, such as answering patients’ questions about their condition. “A panel of dermatologists gave very high ratings to ChatGPT’s answers to common patient queries, such as ‘Can you tell me more about the cause of my eczema?’ or ‘How can I treat eczema flare-ups?’” [8]. Moreover, ChatGPT was considered to be more empathetic than physicians [9].
“Today we still compare patients based on demographic features and general characteristics,” said Dr Zink. “However, this is not a very precise method for patient stratification. For example, Prince Charles and the late Ozzy Osbourne are both males from 1948, raised in the UK, who have been married twice, and lived in castles. Nevertheless, they are completely different individuals with divergent lifestyles, illustrating the limitations of such comparison.”
AI is playing an increasingly important role in medicine, offering communication tools, monitoring instruments, enhancing diagnostic accuracy and other advantages. Importantly, the best outcomes may come from a collaboration between clinicians and AI-based tools, highlighting that AI is not necessarily a replacement for human intervention, but rather an augmentation of the clinical toolkit. At least for now…
- Zink A. Artificial Intelligence. SPIN Dermatology Congress, Paris, France, 2-4 July 2025
- Ates HC, et al. Nature Electronics. 2021;4:13-14
- Ye C, et al. Chem Society Reviews. 2024;53:7960-7982
- Gambhir SS, et al. Sci Transl Med. 2018;10(430):eaao3612
- https://gagadget.com/en/559131-samsung-shows-off-the-micro-led-beauty-smart-mirror-it-can-analyse-skin-and-give-care-recommendations/ visited 5 August 2025
- Jessie GE, et al. Sci Transl Med. 2023;15(681):eabk3489
- Winkler JK, et al. JAMA Dermatology. 2023;159(6):621-627
- Sulejmani P, et al. JEADV. 2024; 38(6):e531-e535
- Ayers JW, et al. JAMA Intern Med. 2023;183(6):589-596
Copyright ©2025 Medicom Medical Publishers
Posted on
Previous Article
« A bright future for vitiligo patients Next Article
Roadmap to systemic treatment of paediatric AD »
« A bright future for vitiligo patients Next Article
Roadmap to systemic treatment of paediatric AD »
Table of Contents: SPIN 2025
Featured articles
A bright future for vitiligo patients
Are we ready to use GLP-1-receptor agonists in psoriasis?
Highlights from SPIN 2025
Broad spectrum of emerging therapies in HS
Roadmap to systemic treatment of paediatric AD
Monitoring the ‘human machine’ with AI
A bright future for vitiligo patients
Are we ready to use GLP-1-receptor agonists in psoriasis?
Psoriasis and tuberculosis in the era of new targeted therapies
Managing children with IMIDs in 2025
Related Articles
February 4, 2022
Improved QoL with axi-cel versus standard-of-care in R/R LBCL
June 14, 2022
Too much hygiene: CD in later life?
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com
